Compare SKM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKM | ALGN |
|---|---|---|
| Founded | 1984 | 1997 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.4B |
| IPO Year | 1999 | 2000 |
| Metric | SKM | ALGN |
|---|---|---|
| Price | $36.33 | $186.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $192.40 |
| AVG Volume (30 Days) | ★ 1.4M | 959.9K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $4.51 | $5.80 |
| Revenue Next Year | $1.85 | $4.59 |
| P/E Ratio | ★ $31.64 | $32.78 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $19.66 | $122.00 |
| 52 Week High | $36.80 | $208.31 |
| Indicator | SKM | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 72.07 | 60.15 |
| Support Level | $20.63 | $159.99 |
| Resistance Level | N/A | $203.25 |
| Average True Range (ATR) | 1.13 | 6.85 |
| MACD | 0.70 | 1.73 |
| Stochastic Oscillator | 88.51 | 93.31 |
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.